Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 1 de 1
Filter
Add more filters










Database
Language
Publication year range
1.
Int J Toxicol ; 33(4): 325-331, 2014 07.
Article in English | MEDLINE | ID: mdl-25038063

ABSTRACT

This study demonstrates that aspartame consumption and insulin treatment in a juvenile diabetic rat model leads to increase in cytochrome P450 (CYP) 2E1 and CYP3A2 isozymes in brain. Diabetes mellitus was induced in postweaned 21-day-old Wistar male rat by streptozotocin. Animals were randomly assigned to one of the following groups: untreated control, diabetic (D), D-insulin, D-aspartame, or the D-insulin + aspartame-treated group. Brain and liver tissue samples were used to analyze the activity of CYP2E1 and CYP3A2 and protein levels. Our results indicate that combined treatment with insulin and aspartame in juvenile diabetic rats significantly induced CYP2E1 in the cerebrum and cerebellum without modifying it in the liver, while CYP3A2 protein activity increased both in the brain and in the liver. The induction of CYP2E1 in the brain could have important in situ toxicological effects, given that this CYP isoform is capable of bioactivating various toxic substances. Additionally, CYP3A2 induction in the liver and brain could be considered a decisive factor in the variation of drug response and toxicity.


Subject(s)
Aspartame/therapeutic use , Cerebellum/enzymology , Cerebrum/enzymology , Cytochrome P-450 CYP2E1/metabolism , Cytochrome P-450 CYP3A/metabolism , Diabetes Mellitus, Type 1/diet therapy , Non-Nutritive Sweeteners/therapeutic use , Animals , Aspartame/adverse effects , Cerebellum/drug effects , Cerebrum/drug effects , Combined Modality Therapy/adverse effects , Cytochrome P-450 CYP2E1/chemistry , Cytochrome P-450 CYP2E1 Inducers/adverse effects , Cytochrome P-450 CYP2E1 Inducers/therapeutic use , Cytochrome P-450 CYP3A/chemistry , Cytochrome P-450 CYP3A Inducers/adverse effects , Cytochrome P-450 CYP3A Inducers/therapeutic use , Diabetes Mellitus, Type 1/blood , Diabetes Mellitus, Type 1/drug therapy , Diabetes Mellitus, Type 1/metabolism , Enzyme Induction/drug effects , Hyperglycemia/prevention & control , Hypoglycemic Agents/adverse effects , Hypoglycemic Agents/therapeutic use , Insulin/adverse effects , Insulin/therapeutic use , Liver/drug effects , Liver/enzymology , Male , Nerve Tissue Proteins/agonists , Nerve Tissue Proteins/metabolism , Neurons/drug effects , Neurons/enzymology , Non-Nutritive Sweeteners/adverse effects , Organ Specificity , Random Allocation , Rats, Wistar
SELECTION OF CITATIONS
SEARCH DETAIL
...